Cara Therapeutics (CARA), GW Pharma (GWPH), Jazz Pharmaceuticals (JAZZ), Zynerba Pharmaceuticals (ZYNE) - CBD Drug Makers, Medical Cannabis Stocks Rally On GW Pharma's Big Buyout
What Happened: Jazz Pharmaceuticals (NASDAQ:JAZZ) for $7.2 billion in cash and stock. The Sympathy Move: The news has set in motion across-the-board strength in cannabinoid drug companies such as Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), and Cara Therapeutics Inc (NASDAQ:CARA). Corbus is a Phase 3 biopharma that is developing lenabasum, an oral, selective cannabinoid receptor type 2 agonist for indications such as systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus. Zynerba's lead asset Zygel is a canna...